Organovo Holdings Inc (NASDAQ:ONVO)
| 1.69 Delayed Data As of Feb 01 |  +0.055 / +3.37%Today’s Change | 1.37 Today|||52-Week Range 4.67 | +19.86% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $14.0M |
Company Description
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Contact Information
Organovo Holdings, Inc. 11555 Sorrento Valley Road San Diego California 92121 |
Employees
Shareholders
| Other institutional | 5.08% |
| Individual stakeholders | 2.34% |
| Mutual fund holders | 12.14% |
Top Executives
| Keith Murphy | Executive Chairman & Chief Executive Officer |
| Thomas P. Hess | Chief Financial & Accounting Officer |
| Jeffrey N. Miner | Chief Scientific Officer |
| Curtis Tyree | Senior VP-Strategy & Business Development |
| Steve E. Kunszabo | VP-Investor Relations & Corporate Communications |
